CLINICAL CASE OF SIMULTANEOUS LAPAROSCOPIC SLEEVE GASTRECTOMY AND HYSTERECTOMY OF UTERINE CANCER FEMALE WITH MORBID OBESITY
https://doi.org/10.17238/issn2072-3180.2020.4.82-94
Abstract
Introduction: endometrial cancer has a direct correlation with obesity. Risks of this type of cancer increase with the body weight gain and expected response to treatment becomes less favorable. Significant and persistent weight loss of hysterocarcinoma female with morbid obesity has a positive impact on oncological results, further quality of life, state of comorbidity. Laparoscopic hysterectomy is a priority treatment of early endometrial cancer. Bariatric surgery is considered to be the most effective and radical method of morbid obesity correction.
Clinical case: the cases of bariatric surgery to influence positively the results of carcinoma treatment outcome before and after the main stage have increased recently. An experience of concurrent simultaneous radical surgery of сancer and morbid obesity correction is isolated worldwide nowadays. We would like to present the clinical case of concurrent laparoscopic sleeve gastrectomy and laparoscopic hysterectomy of a 45-year-old female patient with endometrial carcinoma stage IA, morbid obesity and 2 type diabetes mellitus. The short-term results of this case are 21,2% overweight loss within 2 months, sustained remission of diabetes mellitus, clinical group III.
Discussion: the described case is theoretically justified and has, although few, practical prototypes that appear in publications of recent years after successful clinical application.
Conclusion: the current small world experience of such cases requires further accumulation and development of practical aspects and a more detailed study of this topic.
About the Authors
V. S. SamoylovRussian Federation
Samoylov Vladimir Sergeevich — PhD in Medicine, Bariatric surgeon, oncologist of oncology department № 4
Vaicehovskogo st., 4, Voronezh, 394036
V. V. Popov
Russian Federation
Popov Vadim Viktorovich — PhD in Medicine, Department chair
Vaicehovskogo st., 4, Voronezh, 394036
I. P. Moshurov
Russian Federation
Moshurov Ivan Petrovich — MD, Professor, Head of the Department of Oncology and specialized surgical disciplines at Voronezh State Medical University named after N.N. Burdenko, Chief physician of Budgetary institution of health care of the Voronezh region «Voronezh regional clinical oncological clinic»
Vaicehovskogo st., 4, Voronezh, 394036
A. A. Mihaylov
Russian Federation
Mihaylov Andrey Anatolievich — PhD in Medicine, Chief surgeon
Vaicehovskogo st., 4, Voronezh, 394036
K. I. Gorbunova
Russian Federation
Gorbunova Kristina Igorevna — Oncologist of oncology department № 5
Vaicehovskogo st., 4, Voronezh, 394036
A. V. Stepanenko
Russian Federation
Stepanenko Artem Vladimirovich — Postgraduate at the Department of Faculty Surgery
Studencheskaya st., 10, Voronezh, 394036
References
1. Kravec O.A., Kuznecov V.V. et al. Klinicheskie rekomendacii: Rak tela matki [Clinical guidelines: Uterine cancer], Moscow, 2018, pp. 6–7. (In Russ.)
2. Dossus L., Rinaldi S., Becker S., Lukanova A. et al. Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study. Endocr. Relat. Cancer, 2010; 17(4), рр. 1007–1019.
3. Dedov I.I., Melnichenko G.A., Shestakova M.V., Troshina E.A., Mazurina N.V., Shestakova E.A., Yashkov Yu.I., Neimark A.E. et al. Lechenie morbidnogo ozhirenija u vzroslyh [Morbid obesity treatment in adults]. Ozhirenie i metabolism, 2018, No. 15(1), рр. 53–70. https://doi.org/10.14341/OMET2018153-70 (in Russian)
4. Shafa A., Kumar A., Torres D., McKenzie T.J. Minimally Invasive Hysterectomy and Bariatric Surgery to Improve Endometrial Cancer Survivorship. Obstet. Gynecol., 2019, 134(3), рр. 570–572. https://doi.org/10.1097/AOG.0000000000003403
5. Miheeva Ju.V., Devlicharova N.U. Zabolevaemost’ rakom tela matki v Rossii 2006-2016 [The incidence of endometrial cancer in Russia for 2006–2016]. Issledovanija i praktika v medicine, 2018, Vol. 5, No. 1, pp. 58. https://doi.org/10.17709/2409-2231-2018-5-S1 (in Russian)
6. Michaela A. Onstad, Rosemarie E. Schmandt, and Karen H.Lu. Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment. J. Clin. Oncol., 2016, Dec. 10; 34(35), рр. 4225–4230. https://doi.org/10.1200/jco.2016.69.4638
7. Onstad M.A., Schmandt R.E., Lu K.H. Addressing the role of obesity in endometrial cancer risk, prevention, and treatment. J. Clin. Oncol., 2016, 34, рр. 4225–4228. https://doi.org/10.1200/JCO.2016.69.4638
8. Calle E.E., Kaaks R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer, 2004, 4, рр. 579–591. https://doi.org/10.1038/nrc1408
9. Renehan A.G., Tyson M., Egger M. et al. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet, 2008, 371, рр. 569–578. https://doi.org/10.1016/S0140-6736(08)60269-X
10. Renehan A.G., Soerjomataram I., Tyson M., Egger M., Zwahlen M., Coebergh J.W., Buchan I. Incident cancer burden attributable to excess body mass index in 30 European countries. Int. J. Cancer, 2010, 126, рр. 692–702. https://doi.org/10.1002/ijc.24803
11. Oliver K.E., Enewold L.R., Zhu K., Conrads T.P., Rose G.S., Maxwell G.L., Farley J.H. Racial disparities in histopathologic characteristics of uterine cancer are present in older, not younger blacks in an equal-access environment. Gynecol. Oncol., 2011, 123, рр.76–81. https://doi.org/10.1016/j.ygyno.2011.06.027
12. Bohman Ja.V. Rukovodstvo po onkoginekologii [Gynecological oncology guidelines]. Moscow, M.: Medicina, 1989, 325 p. (In Russ.)
13. Giovanni De Pergola and Franco Silvestris. Obesity as a Major Risk Factor for Cancer. J. Obes., 2013, 29, р.1546. https://doi.org/10.1155/2013/291546
14. Lenz M., Richter T., Muhlhauser I. The morbidity and mortality associated with overweight and obesity in adulthood: a systematic review. Dtsch. Arztebl. Int., 2009, 106(40), рр. 641–648. https://doi.org/10.3238/arz-tebl.2009.0641
15. International Diabetes Federation. IDF Diabetes Atlas, 8th edn. Brussels, Belgium: International Diabetes Federation, 2017.
16. Dedov I., Shestakova M., Benedetti M.M. et al. Prevalence of type 2 diabetes mellitus (T2DM) in the adult Russian population (NATION study). Diabetes Res. Clin. Pract., 2016, 115, рр. 90–95. https://doi.org/10.1016/j.diabres.2016.02.010
17. Buchwald H., Avidor Y., Braunwald E. et al. Bariatric Surgery. JAMA, 2004, 292(14), р. 1724. https://doi.org/10.1001/jama.292.14.1724
18. Freedman D.M., Ron E., Ballard-Barbash R. et al. Body mass index and all-cause mortality in a nationwide US cohort. Int. J. Obes., 2006, 30(5), рр. 822–829. https://doi.org/10.1038/sj.ijo.0803193
19. Guh D.P., Zhang W., Bansback N. et al. The incidence of co-morbidities related to obesity and overweight: A systematic review and metaanalysis. BMC Public Health, 2009, 9(1). https://doi.org/10.1186/14712458-9-88
20. Lenz M, Richter T, Muhlhauser I. The morbidity and mortality associated with overweight and obesity in adulthood: a systematic review. Dtsch. Arztebl. Int., 2009, 106(40), рр.641–648. https://doi.org/10.3238/arztebl.2009.0641
21. Montemorano L., Smrz S.A., Jalilvand A.D., Noria S.F., Salani R. Gynecol. Oncol. Rep., 2019, Jan., 16;27, рр. 69–71. https://doi.org/10.1016/j.gore.2019.01.002
22. Zhang, K., Luo, Y., Dai, H. et al. Effects of Bariatric Surgery on Cancer Risk: Evidence from Meta-analysis. Obes. Surg., 2020, 30, рр.1265–1272. https://doi.org/10.1007/s11695-019-04368-4
Review
For citations:
Samoylov V.S., Popov V.V., Moshurov I.P., Mihaylov A.A., Gorbunova K.I., Stepanenko A.V. CLINICAL CASE OF SIMULTANEOUS LAPAROSCOPIC SLEEVE GASTRECTOMY AND HYSTERECTOMY OF UTERINE CANCER FEMALE WITH MORBID OBESITY. Moscow Surgical Journal. 2020;(4):82-87. (In Russ.) https://doi.org/10.17238/issn2072-3180.2020.4.82-94